Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ATRenew (RERE) Cash & Equivalents (2019 - 2025)

ATRenew (RERE) has disclosed Cash & Equivalents for 7 consecutive years, with $216.8 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents fell 20.97% to $216.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $216.8 million through Dec 2025, down 20.97% year-over-year, with the annual reading at $219.9 million for FY2025, 18.55% down from the prior year.
  • Cash & Equivalents hit $216.8 million in Q4 2025 for ATRenew, down from $274.3 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $274.8 million in Q4 2023 to a low of $212.1 million in Q4 2021.
  • Historically, Cash & Equivalents has averaged $243.5 million across 5 years, with a median of $239.5 million in 2022.
  • Biggest five-year swings in Cash & Equivalents: skyrocketed 53.14% in 2021 and later decreased 20.97% in 2025.
  • Year by year, Cash & Equivalents stood at $212.1 million in 2021, then grew by 12.91% to $239.5 million in 2022, then rose by 14.73% to $274.8 million in 2023, then dropped by 0.19% to $274.3 million in 2024, then decreased by 20.97% to $216.8 million in 2025.
  • Business Quant data shows Cash & Equivalents for RERE at $216.8 million in Q4 2025, $274.3 million in Q4 2024, and $274.8 million in Q4 2023.